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ABSTRACT The structural properties of a crucial transmembrane helix for proton translocation in vacuolar ATPase are studied
using double site-directed spin-labeling combined with electron spin resonance (ESR) (or electron paramagnetic resonance) and
circular dichroism spectroscopy in sodium dodecyl sulfate micelles. For this purpose, we use a synthetic peptide derived from
transmembrane helix 7 of subunit a from the yeastSaccharomyces cerevisiae vacuolar proton-translocating ATPase that contains
two natural cysteine residues suitable for spin-labeling. The interspin distance is calculated using a second-moment analysis of the
methanethiosulfonate spin-label ESR spectra at 150 K. Molecular dynamics simulation is used to study the effect of the side-chain
dynamics and backbone dynamics on the interspin distance. Based on the combined results from ESR, circular dichroism, and
molecular dynamics simulation we conclude that the peptide forms a dynamic a-helix. We discuss this ﬁnding in the light of current
models for proton translocation. A novel role for a buried charged residue (H729) is proposed.
INTRODUCTION
Vacuolar (H1)-ATPase (V-ATPase) is a large multi-protein
membrane-bound enzymatic complex present in almost all
types of eukaryotic cells. The enzyme is anATP-driven proton
pump, acting as amolecularmotor,which is responsible for the
acidiﬁcation of intracellular compartments in eukaryotic cells.
Acidiﬁcation of intracellular compartments or vacuoles is
essential for various cellular processes, including ligand-
receptor dissociation and protein processing and degradation
(1,2). V-ATPases are also found in the cell membranes of
specialized cells, where they function in processes such as
renal acidiﬁcation (3), pH homeostasis of macrophages (4),
and bone resorption (5). Although structural information on
themembrane-bound part of the protein is limited, this kind of
information could be valuable in the search for new therapeutic
agents to treat diseases that are related to bone resorption such
as, for instance, osteoporosis. Moreover, structural studies of
the membrane part of the protein could increase our insight
into the complicated and yet poorly understood mechanism of
protein translocation of V-ATPase.
V-ATPases have a membrane-bound domain, the VO
domain, and a water-soluble domain, the V1 domain. ATP
hydrolysis takes place at the V1 domain, whereas protons are
transported through the VO domain. In yeast, the VO domain
comprises a hexameric ring, which is part of the rotary
motor. It is composed of three different proteolipid subunits
called c (Vma3p, 43), c9 (Vma11p, 13), and c$ (Vma16p,
13). Each of the proteolipid subunits has a single buried
glutamic acid that is essential for proton transport. The
hexameric ring is in contact with subunit a (Vph1p or Stv1p),
which plays the role of a stator in the molecular motor.
Subunit a is thought to provide access for protons to the
buried sites of the proteolipid subunits via two hemichannels
on the cytoplasmic and luminal side of themembrane. Subunit
a is an integral membrane protein containing a cytoplasmic
domain and a membrane-bound domain. The membrane-
bound domain is thought to contain nine transmembrane
helices (6) (for a complete topology model of subunit a, see
Kawasaki-Nishi et al. (6)). The transmembrane (TM) helix 7
(TM7), which is the seventh putative transmembrane segment
of subunit a, was proposed to comprise residues 727–752. It
plays a pivotal role in proton transport, containing an essential
arginine, R735, whose mutation completely inhibits proton
translocation. Moreover it contains two buried histidine
residues, H729 and H743, whose mutation affects proton
transport, although these residues are not absolutely required
for proton transport activity (7,8).
Here, we study a synthetic peptide derived from TM7 of
subunit a from the yeast Saccharomyces cerevisiaeV-ATPase
(Fig. 1, peptide I) using circular dichroism (CD) and electron
spin resonance (ESR) spectroscopy. Model peptides are suit-
able systems for spectroscopic and theoretical studies, since
they give insight into local conformations and interactions that
can be important in the native system (9–12). The amino acid
sequence of this peptide is slightly shifted with respect to TM7,
spanning residues 721–745 from subunit a, to span a small part
of the loop region interconnectingTM7andTM6 that comprises
the putative binding site of the V-ATPase inhibitor baﬁlomycin
(13). The structure of this segment in the intact protein is not
completely clear. Most likely it is helical, extending from the
membrane, as was suggested in the literature (13,14).
Although CD spectroscopy can provide valuable infor-
mation on the secondary structure of a peptide or protein
(15), it is not suitable for obtaining site-speciﬁc information.
For this purpose, we employ ESR spectroscopy in combi-
nation with SDSL (site-directed spin-labeling). For doubly
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spin-labeled proteins, ESR spectroscopy has proven to be
useful as a spectroscopic ruler (16), in particular for
structural studies of membrane proteins (17). The primary
sequence of peptide I contains two native cysteine residues,
C723 and C726, that were speciﬁcally labeled with ESR spin
probes. Using ESR spectroscopy as a spectroscopic ruler,
site-speciﬁc structural information can be obtained on doubly
spin-labeled peptide I. Here, we calculate the interspin dis-
tance between spin-labeled residues C723 and C726 using a
second-moment spectral analysis.
The interspin distance is interpreted using molecular dy-
namics (MD) simulations. To save computer time, a truncated
version of the original peptide containing the cysteine res-
idues was used for theMD simulations (Fig. 1). The sequence
overlaps partly with the loop region interconnecting TM6 and
TM7, and partly with TM7. In the intact protein, TM7 is
adjacent to TM8 of subunit a, and to TM4 of subunit c9.
Hence, in the intact protein, the direct environment of the
studied residues most likely is a combination of other TM
helices, water, and phospholipids. Recently, it was shown that
the structural features of a membrane peptide were similar in
water and in a lipid membrane (18), suggesting that its
conformation is mainly determined by its amino acid
sequence rather than by its direct environment. For this
reason, we use pure water as a solvent in ourMD simulations.
The combined data from CD spectroscopy, ESR spectros-
copy, and MD simulations show that the cytoplasmic part of
the isolated TM7 forms a dynamical a-helix when bound to
sodium dodecyl sulfate (SDS) micelles. This ﬁnding is
discussed in view of the current model for proton transloca-
tion that assumes swiveling of the helices in subunits a and c
upon proton translocation (19).
METHODOLOGY
Peptide design and synthesis
Based on the primary sequence of TM7 from subunit a from yeast (2), a 25-
residue peptide was designed (Fig. 1, peptide I). The peptide was designed to
include the essential arginine R735, which was shown to be absolutely
required for proton translocation, as well as the two nearby histidines H729
and H743. In addition, the peptide was selected to contain two cysteines,
C723 and C725, which are part of the proposed cytoplasmic hemichannel
and loop between TM6 and TM7. These cysteines are suitable targets for
SDSL. A combination of these prerequisites resulted in peptide I, spanning
the amino acid residues 721–745 of subunit a. Throughout this article, the
numbering of the amino acid residues in peptide I will be the same as that
used for the native subunit a (Fig. 1). To enable single cysteine mutants
for SDSL, two additional peptides, II and III, were designed in which
cysteines C723 and C725 were replaced by alanines (Fig. 1). All peptides
were produced by Pepceuticals Ltd (Leicester, UK) on solid support using
continuous-ﬂow chemistry. Peptides were .90% pure, as determined by
high-performance liquid chromatography and mass spectrometry.
Spin-labeling
For spin-labeling, typically an amount of 2.5 mg of peptides I–III was
dissolved in 750 ml dimethylsulfoxide and 250 ml water in a plastic tube.
Subsequently, 100 ml 9.5 mM methanethiosulfonate spin label (MTSSL
(1-oxy-2,2,5,5-tetramethyl-D3-pyrroline-3-methyl)methanethiosulfonate))
stock in dimethylsulfoxide was added and the tube was slowly vortexed for
3 h at room temperature. MTSSL was purchased from Toronto Research
Chemical (Toronto, Ontario, Canada). Small amounts of sample (10 ml)
were stored at 18C for matrix-assisted laser-desorption/ionization time-
of-ﬂight (MALDI-ToF) measurements; the remaining part of the sample was
immediately puriﬁed on a superdex-75 gel column using 10 mM SDS as
eluent, buffered at pH 7.0 with 10 mMNa2HPO4. The ﬂow speed was 60 ml/
min, and every 2 min, a fraction was collected. Fractions containing the spin-
labeled peptides were detected by monitoring the ﬂuorescence at 350 nm
with a Fluor LC 304 by LINEAR, using an excitation wavelength of 280 nm.
Only the fraction with the highest ﬂuorescence intensity was used for further
experiments, typically appearing after ;52 min.
CD measurements
Peptide samples for CD spectroscopy were made up in 50 mM SDS and
buffered at pH 7.0 byNa2HPO4. The ﬁnal peptide concentrationswere 47 and
52 mM for labeled and unlabeled peptide I, respectively. Far-UV CD spectra
were recorded at 20C on a Jasco J-715 CD spectropolarimeter in a 0.1-mm
quartz cuvette and corrected for the SDS background. The cuvette house was
ﬂushed with a constant stream of nitrogen to remove oxygen that could
interfere with the CD measurements. The observed CD signal was converted
to the mean residue ellipticity ([u] in deg cm2 dmol1) as follows (11):
½u ¼ u=10lcn: (1)
FIGURE 1 Putative transmembrane
helix 7 (TM7, gray shaded) of subunit a
of V-ATPase from the yeast Saccharo-
myces cerevisiae (2) and the peptides
used in this work. The numbering of the
amino acid residues corresponds to the
numbering for the native subunit a (6).
Peptide I (gray-shaded sequence) was
used for CD and ESR experiments. The
cysteine residues that were spin-labeled
are indicated by square windows. Pep-
tides II and III are Cys-Ala mutants of
peptide I that were used as references
for the ESR second-moment analysis.
The decapeptide is a truncated version
of MTSSL-labeled peptide I, which was
used exclusively for theMD simulations.
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Here, u is the CD signal in mdeg, l is the optical path length in cm, c is the
concentration of peptide in molars, and n is the number of amino acid
residues in the peptide.
Peptide concentrations were determined based on the absorbance at 280
nm after correcting for the SDS background via the extinction coefﬁcients of
tryptophan, tyrosine, and the nitroxide spin label. For the calculation of the
extinction coefﬁcients, the effects of tryptophan oxidation and incomplete
spin-labeling were taken into account as described elsewhere (20). UV ab-
sorption spectra were recorded in a 1-mm quartz cuvette with a Varian (San
Carlos, CA) Cary 5E at room temperature.
The percentage of a-helix content {a} of the labeled and unlabeled
peptide I was estimated by assuming that the ellipticity at 222 nm is
exclusively due to a-helix conformation (11,21):
fag ¼ ½u222½umax
222
1 k
n
  
3100; (2)
where ½u222 and ½umax222 are the experimental and maximal (39,500 deg
cm2.dmol1) values, respectively, of the ellipticity at 222 nm. The
wavelength dependent constant k is 2.57 at 222 nm.
ESR measurements
ESR spectra were recorded on an X-band ELEXSYS E500 (Bruker, Berlin,
Germany) equipped with a super high-sensitivity probehead in combination
with a SuperX bridge. Temperature was kept at 150 K with a quartz variable
temperature Dewar insert. Spectra were recorded at 20 mT scan widths with
a low microwave power (0.2 mW) to avoid saturation. The ESR spectrum of
doubly spin-labeled peptide I was corrected for singly labeled, noninteract-
ing species based on the MALDI-ToF spectra of peptides II and III. Because
the ESR spectra of spin-labeled peptides II and III were identical, the ESR
spectrum of spin-labeled peptide III was not used in this correction. Details
of the MALDI-ToF work and the correction procedure are described in a
separate article (20).
The distance between two spin labels depends on the second moments of
the ESR spectra via (22,23)
r ¼ 2:32=ðDM2Þ1=6: (3)
Here, r is the distance between the paramagnetic centers in nanometers, and
DM2 is the difference in spectral moment between the doubly (MD) and
singly (MS) labeled spectra in units 10
8 T2:
DM2 ¼ MD MS; (4)
with
MD ¼
R ðB BFDÞ2GDðBÞdBR
GDðBÞdB (5)
and
MS ¼
R ðB BFSÞ2GSðBÞdBR
GSðBÞdB : (6)
Here, GD(B) is the absorption spectrum of the doubly spin-labeled protein
sample andGS(B) is the corresponding spectrum without dipolar interaction.
MD and MS are obtained by numeric integration of the ﬁrst derivative
absorption spectrum. BFD and BFS are the ﬁrst spectral moments of doubly-
and singly labeled peptide, respectively, and B is the magnetic ﬁeld.
Molecular dynamics simulations
To limit the amount of computational time, a truncated version of peptide I
was used for the MD simulations. This artiﬁcial decapeptide comprises
amino acid residues 721–730 (Fig. 1) and includes cysteine residues C723
and C726, which were used in the spin-labeling work. Although high-
resolution data of subunit a are not available at this moment, it has been
suggested that residues 721–727 are a-helical, extending toward the
cytoplasm (13,14). Residues 728–730 are also expected to be a-helical,
since they are part of TM7 (6). Therefore the backbone dihedral angles of the
starting conformation of the decapeptide were set to the values of an ideal
a-helix, being f ¼ 62 and c ¼ 41 (24). To investigate the effect of
biasing toward an a-helical starting conformation, a second simulation was
performed with a 310-helical starting conformation, using dihedral angles of
f¼49 and c¼26. In both simulations, the dihedral angles of the side
chains were initially set to an all-trans conﬁguration.
MD simulations were performed with the GROMACS software package
(25,26), using the GROMOS96 force ﬁeld (27). The force ﬁeld of the spin-
labeled cysteine residuewasmade based on the building blocks of cysteine and
TEMPO that are part of the standard GROMOS96 force ﬁeld, and can be
obtained from the authors on request. For the natural protein, residues 721–730
of subunit a are located in or close to the cytoplasm (2). For this reason, the
artiﬁcial decapeptidewas solvated in explicit single-point-chargewater, using a
total of;2000water molecules. A triclinic box was used with box dimensions
a ¼ b ¼ c ¼ 4.0 nm; the net charge was 0. The energy of the system was
minimized using a steepest-descent algorithm. The ﬁnal coordinates from the
minimization were used for two 20-ns production runs. During the ﬁrst part of
the simulations (0–10 ns), a restraining potential of 1000 kJ mol1 nm2 was
applied on the Ca atoms to keep the peptide in an a- or 310-helical conforma-
tion. This restraining potential was released during the second part (10–20 ns)
of the production run. The MD simulations were carried out using periodic
boundary conditions. The temperature was controlled by coupling separately
the peptide and the water to a temperature bath at 325 K using a Berendsen
thermostat (28). A constant pressure of 1 bar was applied independently in all
three directions using a coupling constant of 0.5 ps. Nonbonded interactions
were treatedwith a twin-rangecutoff scheme.Within a short-range cutoff radius
of 0.8 nm, the interactions were evaluated at every time step based on a pair list
that was updated every ﬁve steps. Intermediate-range interactions up to a long-
range cutoff of 1.4 nm were evaluated with every pair list update and assumed
constant in between. To account for electrostatic interactions beyond the long-
range cutoff radius, a reaction-ﬁeld approximation was applied (29,30) using a
relative dielectric permittivity of 54 for the solvent.
RESULTS
Circular dichroism
The CD spectrum of MTSSL-labeled peptide I in SDS
micelles (Fig. 2) has two minima at 208 and 222 nm,
indicative for an a-helix. Using Eq. 2, the a-helix content
{a} was calculated to be 32 6 3%. The unlabeled peptide I
has minima at slightly different wavelengths: 209 and 224
nm, also suggesting an a-helical conformation. For this
peptide, the calculated a-helix content is 33 6 3%.
For an ideal a-helix, the value of the ratio of the peak
intensities at 208 and 222 nm, [u]222/[u]208, typically is 0.83
(31). A value .1 is an indication for the formation of coiled
coils (11,32). The CD spectrum of labeled peptide I gives a
ratio of 0.88, which is close to the value of an ideal a-helix.
For the unlabeled peptide I, this ratio is 1.05, suggesting the
formation of coiled coils.
ESR spectroscopy
For rapidly tumbling peptides, the dipole-dipole interaction
tensor between the two spin labels averages to zero and does
not contribute to the ESR spectrum. Therefore, the ESR
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spectra were recorded at 150 K, where motional averaging
effects are not present (33). The ESR spectra of singly labeled
peptide II and doubly labeled peptide I in frozen solution at
150 K are presented in Fig. 3, A and B, respectively.
The ESR spectrum of singly labeled peptide II (Fig. 3 A),
in which there are no interacting spin labels, has the
characteristic shape of a powder spectrum, indicating that the
spin labels are immobilized on the ESR timescale. The ESR
spectrum of doubly labeled peptide I (Fig. 3 B) is clearly
broadened with respect to the singly labeled peptide II due to
dipolar interaction. Consequently, the second moment of the
doubly labeled peptide is larger than the second moment of
the singly labeled species (see Table 1). From Eq. 3, the
interspin distance was calculated from the difference in
second moments to be r ¼ 0.94 6 0.06 nm.
For the interpretation of the ESR results it is crucial that the
dipolar broadening in doubly spin-labeled peptide I arises from
intra and not from intermolecular interactions. To check
whether aggregates were formed due to noncovalent protein-
protein interactions, the peptide sample was titrated with a
concentrated SDS stock solution of 0.3 M, buffered at pH 7.0.
SDS is knownas a strongdetergent that has the ability todisrupt
noncovalent protein-protein interactions; hence, an excess of
SDS is expected to disrupt peptide aggregates when present
(34). For SDS/peptide ratios of 1:900 and 1:1600 the interspin
distanceswere identicalwithin the experimental error, showing
that the peptides were essentially monomeric. This strongly
indicates that the dipolar interaction is intramolecular.
DISCUSSION
Circular dichroism spectroscopy
The CD spectra of labeled and unlabeled peptide I are almost
similar in terms of intensity and shape, indicating that overall
their conformations are approximately the same. The inten-
sity in the spectra is strongly reduced as compared to an ideal
a-helix, leading to an a-helix content of ;32%. We ascribe
this reduction in CD signal and the corresponding low
a-helix content to dynamics of the peptide backbone. Small
a-helical peptides are expected to behave as ﬂuctuating
semibroken rods (35). From theoretical studies, it is known
that smaller helices give a lower mean residue ellipticity
(36). Therefore, breaking up an a-helix into smaller a-helical
segments will lead to a CD signal with a reduced intensity.
Thus, the CD results could indicate that peptide I is a ﬂexible
a-helix undergoing rapid changes between multiple confor-
mational states.
X-ray studies of spin-labeled proteins have demonstrated
that MTSSL is generally well tolerated in a-helical structures
(37,38). Also in our study, the CD spectra of labeled and
unlabeled peptides are similar, indicating that the structure is
not affected by the presence of the spin labels. Nevertheless,
a small difference is seen in the ratio [u]222/[u]208. For
labeled peptide I, the value of [u]222/[u]208 is well below 1,
indicating monomeric a-helices. For the unlabeled peptide I,
[u]222/[u]208 is 1.05, suggesting the formation of a coiled-coil
structure. Previously, it has been shown that a single cysteine
residue can promote the formation of coiled coils via the
formation of disulﬁde bridges (39,40). Our peptide has two
FIGURE 2 CD spectra of the spin-labeled (black) and unlabeled peptide I
(gray) in 50 mM SDS micelles, buffered at pH 7.0 by Na2HPO4. The spin
label used is MTSSL. Peptide concentrations were 47 and 52 mM for labeled
and unlabeled peptide I, respectively. Spectra were recorded at 20C.
FIGURE 3 ESR spectra of the singly labeled peptide II (A) and doubly
labeled peptide I (B) in 50 mM SDS, buffered at pH 7.0 by Na2HPO4. The
spin label used is MTSSL. Peptide concentrations were 16 and 47 mM for
peptides II and I, respectively. The spectrum of doubly labeled peptide I was
corrected for the contribution of noninteracting spin labels based on
MALDI-ToF mass spectrometry using the spectrum of peptide II (20). The
temperature is 150 K.
TABLE 1 Parameters for the interspin distance calculation
using the second-moment analysis of the ESR spectra in Fig. 3
MS/10
8 T2 MD/10
8 T2 DM2/10
8 T2 r/nm
390 6 5* 622 6 5* 232 6 7 0.94 6 0.06
*Error limit taken from Wegener et al. (55).
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native cysteine residues that enable the formation of cysteine
cross-links, probably promoting the formation of coiled-coil
structures. When the spin labels chemically block the cys-
teine residues, there is no indication for coil-coil formation.
This suggests that the presence of the chemically reactive
cysteine residues is the determining factor for the formation
of a coiled coil. Therefore we interpret the formation of
coiled coils in the case of unlabeled peptide I as an artifact
related to the chemical properties of the peptide rather than
an intrinsic property of the amino acid sequence.
ESR spectroscopy
For a perfect a-helix, the interspin distance of 0.94 nm can be
related to the structure of the peptide via a simple calculation.
In a simpliﬁed model, the spin labels are regarded as a rigid
stick. This stick is deﬁned as the line perpendicular to the helix
axis intersecting the cysteine Cb-atom. For MTSSL, the
length of the stick was estimated to be 0.7 nm (16). We deﬁne
the interspin distance as the distance between the ends of the
two sticks. In our case, with the spin label attached to cysteine
residuesC723 andC726, the interspin distance is calculated to
be 0.80 nm. This simple calculation already shows that the
peptide does not form an ideal a-helix.
A similar calculation was carried out for a perfect 310-
helix. These helices are frequently found in small membrane
peptides (41), because in a 310-helix the free-energy loss
associated with unsatisﬁed hydrogen bonds at the termini is
smaller than in an a-helix (42). In the case of a 310-helix, the
calculated interspin distance is 0.60 nm (see Table 2), which
is even less in agreement with the experimental value. The
observation that the distances are smaller than the distance
calculated from the second-moment analysis can be ex-
plained by dynamics of the spin-labeled side chains, or by
the fact that the backbone of the peptide is ﬂexible, resulting
in a nonperfect helical conformation.
To test these ideas, the effect of side-chain dynamics on
the interspin distance was investigated by performing MD
simulations that explicitly take into account the force ﬁeld and
molecular structure of MTSSL. To reduce the computer time,
we constructed an artiﬁcial decapeptide, which is a truncated
version of the original peptide containing cysteine residues
C723 and C726 (Fig. 1). In the intact protein, lateral forces
arising from the connecting loop region between TM6 and
TM7 could cause forced bending of the amino acid sequence
studied here, prohibiting the formation of an a-helical
structure in the loop. However, since the loop is sufﬁciently
long to accommodate lateral forces (74 amino acid residues,
as compared to ;10 residues for a typical loop region), we
assume that a forced bending of the loop region does not affect
the structure of the amino acid sequence. In the ﬁrst part of the
MD simulation (0–10 ns), the backbone of the decapeptide
was kept in a ﬁxed 310 or a-helix conformation by putting a
restraining potential on the Ca atoms. For ana-helical starting
conformation, the MD result is shown in Fig. 4. The number
of amino acid residues in an a-helical conformation is six to
seven, close to the maximal value of eight. Note that the
‘‘deﬁne secondary structure of proteins’’ (DSSP) algorithm
(43) that is used to calculate the a-helical residues does not
count the terminal residues of the decapeptide, since no
sufﬁcient hydrogen bonds can be formed with adjacent
residues in the termini. Occasionally, a few residues are in a
310-helix conformation. Initially (0–2 ns), the interspin
distance ﬂuctuates rapidly with values between 0.5 and 1.2
nm. These ﬂuctuations probably arise from the rather arbitrary
(all-trans) conﬁguration of the side chains. After 2 ns, the
interspin distance ﬂuctuates mostly between 0.5 and 0.9 nm.
To minimize effects of the starting conformation, the time-
averaged interspin distance was calculated for the last 5 ns
(5–10 ns) (see Table 2). The value of 0.79 nm is in excellent
agreement with the value calculated for the simple helical
model (0.80 nm), indicating that dynamics of the peptide
backbone and the related distortion of the backbone
conformation are responsible for the increase in interspin
distance. The distance distribution over the last 5 ns of MD
simulation (5–10 ns) is shown in Fig. 5. A strong peak is
found at a distance of 0.90 nm, and a smaller one at 0.65,
arising from different rotameric states of the spin label. This
indicates that multiple rotameric states are accessible, despite
the fact that the backbone is kept in a ﬁxed a-helix.
The same approach was taken to calculate the interspin
distance for a 310-helical starting conformation, also time-
averaging the interspin distance over the last 5 ns of MD
simulation (see Table 2). The averaged interspin distance of
0.65 nm is also close to the value calculated for the simple
model (0.60 nm). This could indicate that for a- and 310-
helices with a rigid backbone, a simple stick model is
sufﬁcient to calculate the interspin distance. Since the
calculated average distances for both an a-helix and a 310-
helix are close to the distances calculated with the simple
helical models, and since the distances are smaller than the
value that was calculated with the second-moment analysis,
we conclude that the peptide does not form a rigid a- or 310-
helix. Possibly, dynamics of the peptide backbone and the
related distortion of the backbone conformation are respon-
sible for the increase in interspin distance.
To test the effect of ﬂexibility of the backbone on the
interspin distance, the restraining potential was removed
TABLE 2 Interspin distances calculated for a simple helix
model and for MD trajectories of spin-labeled artiﬁcial
decapeptide starting from a- and 310-helix conformations
Average interspin distance (nm)
Model type
Time interval
(ns)
310-Helix starting
conformation
a-Helix starting
conformation
Simple helix NA 0.60 0.80
Restrained backbone 5–10 0.65 0.79
Free backbone 15–20 0.83 0.89
Decapeptides are Peptides I–III, as described in Fig. 1. NA, not applicable.
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after the ﬁrst 10 ns of the MD simulations (Fig. 4, black
arrow). As can be seen for an a-helical starting conforma-
tion, this results in a reduction of the number of residues in
an a-helical conformation to four to six. In the ﬁrst 3 ns after
releasing the backbone constraints (10–13 ns), about half of
all amino acid residues are in a p-helix conformation. The
p-helix never persists longer than 90 ps, indicating that the
p-helix is not very stable. The presence of a metastable
p-helix conformation is interesting. Although a clear role of
the p-helix has not been established in protein structure and
function (44,45), it has been suggested that the p-helix is a
metastable helix that marks systems with a high propensity
for conformational transitions (46). We therefore regard the
p-helix as a metastable structure indicating a conformational
ﬂexibility of the peptide. Nevertheless, the p-helix may still
be an artifact of simulations on small peptides. In the
GROMOS96 force ﬁeld, it is actually favored over the
a-helix by0.3 kcal/mol (47). Therefore, it could be that the
amount of p-helix in the MD simulations is overestimated.
Throughout the last part of the simulation (12.5–20 ns),
the a-helix is the dominant structure. The formation of the
p-helix is accompanied by a sudden increase in interspin dis-
tance, ﬂuctuating between 1.2 and 1.8 nm. Once the a-helix
is formed, the interspin distance decreases to ,1.0 nm, with
another increase between 16 and 17.5 ns. However, this
second increase in interspin distance is not accompanied by
the formation of a p-helix.
To minimize the effect of the starting structure, the average
interspin distance was calculated for the last part of the
simulation (15–20 ns). In this part of the simulation, the time-
averaged interspin distance is 0.89 nm, which is in good
agreement with the value of 0.946 0.06 nm calculated from
the second-moment analysis. As compared to the restrained
part of the MD simulation, the distance distribution broadens
and peaks appear at 0.70, 0.85, 1.00, and 1.20 nm, probably
arising from an increase in rotameric states of the spin label.
Therefore, the increase of the average interspin distance can
be explained by ﬂexibility of the peptide backbone, even
though the peptide remains a-helical most of the time. For a
310-helical starting conformation, a similar MD simulation
results in an average distance of 0.83 nm (see Table 2).
Although this average distance is smaller than in the case of an
a-helical starting conformation (0.89 nm), the average
distance is strongly increased with respect to the ﬁxed 310-
helix (0.65 nm). Also, this interspin distance is larger than in
the case of a ﬁxed a-helix (0.79 nm). This could suggest that
FIGURE 4 Number of helical residues in terms of 310-
helix (n), a-helix (dashed lines), andp-helix (:) (left axis)
and interspin distance (right axis) in the MD simulation of
the MTSSL-labeled artiﬁcial decapeptide starting from an
a-helix conformation. The interspin distance is deﬁned as
the distance between the centers of mass of the nitroxide
groups. During the ﬁrst half of the simulation (0–10 ns), a
restraining potential on the Ca atoms was used to keep the
peptide in an a-helix conformation. The arrow indicates
the time (10 ns) at which the restraining potential was
removed. Snapshots were taken every 10 ps. Helix types
were assigned according to the DSSP algorithm (43). Note
that this algorithm does not count the terminal amino acid
residues. Because of crowding of the data points on the
horizontal axis, they are not shown (most of the time, the
number of residues in the 310- or p-helix is zero).
FIGURE 5 Interspin distance distributions from the MD trajectory of the
MTSSL-labeled artiﬁcial decapeptide starting from an a-helix conforma-
tion. (Gray line) Distances taken from the 5–10 ns part of the simulation in
the presence of a restraining potential on the Ca atoms to keep the peptide in
an a-helix conformation. (Black line) Distances taken from the 15–20 ns part
of the simulation after release of the restraining potential at 10 ns. Interspin
distances were taken from 10-ps snapshots. The arrow indicates the interspin
distance calculated from the second-moment analysis (0.94 nm). The area of
the distributions is normalized to 1.
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both simulations converge to a similar structure, independent
of the starting conformation used. Relaxation dynamics of
secondary structure can occur on much larger timescales than
the timescales used in our work (48), which might explain the
small difference between the average interspin distance
calculated for a ﬂexible a-helix and a ﬂexible 310-helix.
Despite the fact that the interspin distance calculated from
second-moment analysis represents a spatial average over a
frozen distribution of conformations at 150 K, and the
interspin distances from the MD simulations represents a
time-average in the nanosecond range at 325 K, the good
correspondence between the two averages is striking. Based
on this result, we conclude that the peptide forms a ﬂexible
a-helix when bound to SDS micelles.
To illustrate the location of the a-helical residues in the
second part of the simulations, the percentage of a-helix
conformation per residue is plotted for both an a-helical and
a 310-helical starting conformation in Fig. 6 (black bars and
red bars, respectively). To limit biasing of the results toward
the starting conformation, the percentage of a-helix per
residue was averaged over the last 5 ns of the simulation (15–
20 ns). Note, again, that the DSSP algorithm does not count
the terminal amino acid residues E721 and T730. From this
plot, it can be seen that residues F722–V727 form a rel-
atively stable a-helical core around cysteine residues C723
and C726. Residues S728 and H729 do not show a sig-
niﬁcant percentage of a-helix, suggesting a more ﬂexible
conformation in the C-terminal domain of the decamer.
In the case of a 310-helical starting conformation, it is
observed that the 310-helix converts rapidly into ana-helix. In
fact, the percentage of 310-helix is negligible over the unre-
strained part of the simulation (10–20 ns, data not shown).
However, the percentage of a-helix per residue is slightly
lower in the case of a 310-helical starting conformation com-
pared to the simulation with an a-helical starting conforma-
tion. This small difference can be explained by the fact that
the simulation time may be too short to ensure complete
convergence. Taking all MD results together, we conclude
that the amino acid sequence from F722 to V727 has a strong
intrinsic tendency to form an a-helix. In comparison, S728
and H729 are relatively ﬂexible.
In thiswork,wehave employed a combined approachofCD
spectroscopy, ESR spectroscopy, molecular modeling, and
MDsimulations to study the characteristics of a peptide I that is
derived from an essential part of the proton translocation
domain ofV-ATPase. The results fromCDspectroscopy show
that the presence of the spin label does not have a pronounced
effect on the conformation of the peptide. In addition, the CD
results suggest that peptide I is ﬂexible a-helix. The ESR
results clearly indicate that the peptide is not a rigid a-helix,
since the interspin distance is increased compared to that of a
rigid a-helix. By using MD simulations we show that this
increased interspin distance cannot be explained solely by
side-chain dynamics, but results from backbone ﬂexibility.
The amino acid sequence of peptide I (V721–Q745) over-
laps with the putative a-helical TM7 of V-ATPase subunit a
(6), which was predicted to comprise amino acid residues
V727–T752. Residues E721–C726 of peptide I overlap with
the putative cytoplasmic loop between TM6 and TM7. There
is evidence from the literature that these amino acid residues
are also in an a-helical conformation (13,14). Our spectro-
scopic results and MD simulations converge to support the
view that peptide I is in an a-helical, albeit ﬂexible, structure,
suggesting that the amino acid sequence has a strong intrinsic
propensity to adopt an a-helical conformation.
The increased ﬂexibility of the C-terminus of the decapep-
tide with respect to the N-terminus is interesting. Previously it
was shown in both experimental (49) and theoretical (50)
work that in an a-helix, the two termini are not equivalent. In
general, the backbone carbonyl groups of the last three
residues of an a-helix are not hydrogen-bonded. Therefore,
the backbone entropy of the C-terminus is larger than in the
N-terminus, making the C-terminus more ﬂexible than the
N-terminus. Most likely, the increased ﬂexibility of residues
S728 and H729 reﬂects this phenomenon.
In addition, the backbone displays another type of ﬂexi-
bility, possibly due to thermal motions of the peptide back-
bone. Because of this, the number of rotameric states that are
accessible increases, giving an overall increase in the interspin
distance. Therefore, the combined results from the ESR
experiment and the MD simulations could be explained by
assuming that the peptide forms an a-helix, and that the
increase in interspin distance arises from thermal ﬂuctuations.
However, the calculated a-helix content of stable isolated
transmembrane peptides bound to SDS micelles typically
ranges from 60% to 80% (11), whereas our CD results give a
calculateda-helix content of 33%.Moreover, the presence of a
metastable p-helix indicates that the system has a high
propensity for conformational transitions (46). We ascribe the
low percentage of a-helix and the presence of a p-helix by
FIGURE 6 The percentage of a-helix per residue of the amino acid
residues calculated from the MD trajectories of the MTSSL-labeled artiﬁcial
decapeptide starting from an a-helical conformation (black bars) and from a
310-helical conformation (gray bars). The percentage of a-helix was
calculated according to the DSSP algorithm (43). Note that this algorithm
does not count the terminal amino acid residues. To limit biasing of the
results toward the starting conformation, the percentage of a-helix per
residue was an average over the last 5 ns of the simulation (15–20 ns).
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assuming that the a-helix breaks up into smaller fragments on
the ns timescale, analogous to the model presented in the
literature that assumes that a-helical peptides behave as
ﬂuctuating semibroken rods (35) that can twist and reorient
independently of each other. Such breaking up of the a-helix
would explain the lower CD signal, since smaller a-helices
give a lower CD signal (36). This model is in good agreement
with our ﬁnding of a p-helix, since the presence of a p-helix
indicates that the region containing the cysteine residues has a
highpropensity to undergo conformational transitions, such as,
for instance, breaking up of the helix into smaller fragments.
Proton translocation in V-ATPase subunit a is thought to
occur through a rotary mechanism, in which arginine R735
in TM7 is brought into close proximity to the speciﬁc
glutamic acid residues in the subunit c assembly, facilitating
proton release (51). Cysteine cross-linking studies have
indicated that TM7 of subunit a and TM4 of subunit c9 are in
close proximity in the V-ATPase, but the results were not
consistent with a unique orientation of these two helical
segments with respect to each other. Because of the diversity
of the sites that could be cross-linked between TM7 and
TM4, it was suggested that one or both of these helices could
rotate with respect to each other (52). In this light, our
ﬁnding of an a-helix breaking up into smaller fragments is
interesting, since the helix swiveling that was found in the
literature could be equivalent to the twisting of smaller
fragments with respect to each other in our peptide model.
For instance, breaking or loosening of the helix at the
position of the cysteine residues would enable twisting of the
TM-section with respect to the section toward the cytoplasm,
moving independently of the cytoplasmic loop region.
We speculate that twisting or swiveling of TM7 is
important for the gating of the cytoplasmic proton hemi-
channel, similar to the gating mechanism in other pore-lining
helices of other ion channels, such as the nicotinic acetyl-
choline receptor (53). Interestingly, also in the case of the
ErbB-2 tyrosine kinase receptor, a a/p-helix transition
was found, causing a rotation of 100 about the helix axis,
inducing changes in the distribution of the residues along the
helix faces (54). For comparison, TM7 is thought to undergo
a rotation of 60–90 during proton transport (51). The
swiveling could thus be important for the positioning of
residues that are involved in channel gating, possibly H729,
whose mutation has been shown to affect protein activity (6).
At the same time, swiveling of the helix could be important
for the positioning of the essential R735, allowing interaction
with the glutamic acid residue of either subunit c9 or c$,
facilitating release of the proton into the luminal hemi-
channel. The V-ATPase inhibitor baﬁlomycin was shown to
interact with residues E721, L724, and N725 (13). Based on
our concept, inhibitor binding could rigidify the helix,
thereby hampering or blocking proton translocation.
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